Table of Contents Author Guidelines Submit a Manuscript
International Journal of Medicinal Chemistry
Volume 2013, Article ID 467383, 4 pages
http://dx.doi.org/10.1155/2013/467383
Research Article

A Possible Molecular Mechanism of Immunomodulatory Activity of Bilirubin

Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, 147 Shimokasuya, Kanagawa, Isehara 259-1143, Japan

Received 17 January 2013; Revised 24 March 2013; Accepted 25 March 2013

Academic Editor: Armando Rossello

Copyright © 2013 Hideto Isogai and Noriaki Hirayama. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. W. Sedlak and S. H. Snyder, “Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle,” Pediatrics, vol. 113, no. 6, pp. 1776–1782, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Liu, P. Li, J. Lu et al., “Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis,” Journal of Immunology, vol. 181, no. 3, pp. 1887–1897, 2008. View at Google Scholar · View at Scopus
  3. D. Fischman, A. Valluri, V. S. Gorrepati, M. E. Murphy, I. Peters, and P. Cheriyath, “Bilirubin as a protective factor for rheumatoid arthritis: an NHANES study of 2003–2006 data,” Journal of Clinical Medicine Research, vol. 2, no. 6, pp. 256–260, 2012. View at Google Scholar
  4. F. Peng, X. Deng, Y. Yu et al., “Serum bilirubin concentration and multiple sclerosis,” Journal of Clinical Neuroscience, vol. 18, no. 10, pp. 1355–1359, 2011. View at Google Scholar
  5. L. Vítek, L. Muchová, E. Jančová et al., “Association of systemic lupus erythematosus with low serum bilirubin levels,” Scandinavian Journal of Rheumatology, vol. 39, no. 6, pp. 480–484, 2010. View at Google Scholar
  6. MOE (Molecular Operating Environment), 01, Chemical Computing Group: Montreal, Canada, 2011.
  7. P. Labute and M. Santavy, “Locating Binding Sites in Protein Structures,” Journal Chemical Computing Group, 2007, http://www.chemcomp.com/journal/sitefind.htm.
  8. J. Goto, R. Kataoka, H. Muta, and N. Hirayama, “ASEDock-docking based on alpha spheres and excluded volumes,” Journal of Chemical Information and Modeling, vol. 48, no. 3, pp. 583–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. R. Corbeil, C. I. Williams, and P. Labute, “Variability in docking success rates due to dataset preparation,” Journal of Computer-Aided Molecular Design, vol. 26, no. 6, pp. 775–786, 2012. View at Google Scholar
  10. P. T. Illing, J. P. Vivian, N. L. Dudek et al., “Immune self-reactivity triggered by drug-modified HLA-peptide repertoire,” Nature, vol. 486, no. 7404, pp. 554–558, 2012. View at Google Scholar
  11. F. C. Bernstein, T. F. Koetzle, and G. J. B. Williams, “The protein data bank: a computer based archival file for macromolecular structures,” Journal of Molecular Biology, vol. 112, no. 3, pp. 535–542, 1977. View at Google Scholar · View at Scopus
  12. A. F. McDonagh, L. A. Palma, and D. A. Lightner, “Blue light and bilirubin excretion,” Science, vol. 208, no. 4440, pp. 145–151, 1980. View at Google Scholar · View at Scopus
  13. M. Levitt, “Accurate modeling of protein conformation by automatic segment matching,” Journal of Molecular Biology, vol. 226, no. 2, pp. 507–533, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Fechteler, U. Dengler, and D. Schomburg, “Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria,” Journal of Molecular Biology, vol. 253, no. 1, pp. 114–131, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Weiner, P. A. Kollman, D. T. Nguyen, and D. A. Case, “An all atom force field for simulations of proteins and nucleic acids,” Journal of Computational Chemistry, vol. 7, no. 2, pp. 230–252, 1986. View at Google Scholar
  16. N. M. Khan and T. B. Poduval, “Immunomodulatory and immunotoxic effects of bilirubin: molecular mechanisms,” Journal of Leukocyte Biology, vol. 90, no. 5, pp. 997–1015, 2011. View at Google Scholar